Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
20%(1 trials)

Phase Distribution

Ph phase_2
4
80%
Ph phase_1
1
20%

Phase Distribution

1

Early Stage

4

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
4(80.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(5)

Detailed Status

Completed5

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (20.0%)
Phase 24 (80.0%)

Trials by Status

completed5100%

Recent Activity

0 active trials
Showing 5 of 5
completedphase_2

2013/2017 H7N9 Prime-Boost Interval

NCT03589807
completedphase_1

A Phase I Study Priming With an Inactivated A/H7N9 Influenza Virus Vaccine With or Without MF59 Adjuvant Followed by Live Attenuated A/H7N9 Influenza Virus Vaccine

NCT02251288
completedphase_2

H7N9 Mix and Match With AS03 and MF59 in Healthy Adults

NCT01942265
completedphase_2

H7N9 Mix and Match With MF59 in Healthy Elderly Persons

NCT02213354
completedphase_2

H7N9 Mix and Match With MF59 in Healthy Adults

NCT01938742

Clinical Trials (5)

Showing 5 of 5 trials
NCT03589807Phase 2

2013/2017 H7N9 Prime-Boost Interval

Completed
NCT02251288Phase 1

A Phase I Study Priming With an Inactivated A/H7N9 Influenza Virus Vaccine With or Without MF59 Adjuvant Followed by Live Attenuated A/H7N9 Influenza Virus Vaccine

Completed
NCT01942265Phase 2

H7N9 Mix and Match With AS03 and MF59 in Healthy Adults

Completed
NCT02213354Phase 2

H7N9 Mix and Match With MF59 in Healthy Elderly Persons

Completed
NCT01938742Phase 2

H7N9 Mix and Match With MF59 in Healthy Adults

Completed

All 5 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
5